Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Chugai Pharmaceutical Co ( (JP:4519) ) just unveiled an announcement.
In its 2024 financial results, Chugai Pharmaceutical reported a notable increase in revenues and profits, with a 5.3% rise in revenues and a 23.4% increase in operating profit compared to the previous year. The company also announced a significant increase in dividends, reflecting its strong financial performance and marking its 100th anniversary with special dividends, indicating a positive outlook for shareholders.
More about Chugai Pharmaceutical Co
Chugai Pharmaceutical Co., Ltd., listed on the Tokyo Stock Exchange, operates in the pharmaceutical industry. The company is known for developing and marketing innovative medicines, focusing on oncology, rheumatology, and renal diseases.
YTD Price Performance: -7.82%
Average Trading Volume: 7,366
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $67.98B
For a thorough assessment of 4519 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue